Kuzmanovska, Sonja
Preferred name
Kuzmanovska, Sonja
Official Name
Kuzmanovska, Sonja
Translated Name
Кузмановска Соња,
Alternative Name
S. Kuzmanovska
Kuzmanovska.S
Sonja Kuzmanovska
Kuzmanovska S
С. Кузмановска
Кузмановска С
Кузмановска. С
Кузмановска Соња
Main Affiliation
Email
skuzmanovska@medf.ukim.edu.mk
skuzmanovska@gmail.com
40 results
Now showing 1 - 10 of 40
- Some of the metrics are blocked by yourconsent settings
Item type:Publication, Молекуларна нуклеарна медицина: први искуства со визуализација на дистрибуцијата на соматостатинските рецептори(Medical Faculty, Ss. Cyril and Methodius University in Skopje, 2011); ; ;Здравеска-Кочовска М - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Universal salt iodization potentially contributes to health equity: socio-economic status of children does not affect iodine status(Walter de Gruyter GmbH, 2022-09-27) ;Milevska-Kostova, Neda; ; ; Ittermann, TillMany studies have shown that socio-economic status (SES) contributes to health inequalities, with nutrition as one of the major risk factors. Iodine intake entirely depends on external sources, and deficiencies are known to be more prevalent in lower social groups, especially in countries with limited access to iodized salt. This study aimed to determine the influence of SES on iodine status and iodine availability from household salt in North Macedonia. - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Relationship between plasma cortizol levels and score of depression in heroin addicts of methadone treatment(De Gruyter, 2014) ;D. Janicevic-Ivanovska ;A. Spasovska-Trajanovska ;P. Gun Atak ;S. Domazetovska - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Effects of Rosuvastatin Versus Atorvastatin, Alone or in Combination, on Lipoprotein (a): A Single-Center Study(aop.sagepub.com, 2016); ; ;Daka, Arlinda; Domazetovska, SaskaBackground: There are little evidences about the therapeutic efficacy of different lipid-lowering agents in the reduction of elevated lipoprotein(a) [Lp(a)]. Objective: testing the effect of different lipid-lowering agents on elevated Lp(a). Methods: prospective interventional study performed in patients with CAD, or high CAD risk, with Lp(a), >50 mg/dL. Lp(a), total cholesterol (C), HDL-C, LDL-C, triglycerides (TGs), apolipoprotein (Apo) A1, Apo B, enzymes of myocyte and hepatic injury were comparatively analyzed between 4 lipid-lowering strategies: rosuvastatin (R group) 40 mg, atorvastatin (A group) 80 mg, atorvastatin 40 mg add-on micronized fenofibrate (A+F group), and atorvastatin 40 mg add-on 1 g extended-release niacin (A+ERN group). Comparison was made for their therapeutic efficacy on Lp(a), and safety. Results: 87 patients with mean Lp(a) 94.6 ± 39.6 mg/dL were analyzed. Groups: 25 patients in the R, 22 in the A, 20 in the A+F and 20 in A+ERN group. Significant reduction in all lipid fractions in all treatment groups was reported after 6 months. The average reduction of Lp(a) was 15.9 ± 21.0 mg/dL, with: 18.2 ± 24.8 (P = 0.001) in the R group, 17.3 ± 10.4 (P = 0.001) in A+F, 19.5 ± 10.9 (P = 0.001) in A+ERN and the lowest in the A group (11.24 ± 22.91, P = 0.032). No adverse effects were observed in any of the treatment groups. Conclusions: When compared with atorvastatin, it seems that rosuvastatin can achieve more significant decrease of Lp(a).The efficacy of the second one can be increased by adding fibrate or ERN. - Some of the metrics are blocked by yourconsent settings
Item type:Publication, ''Ïn house'' preparation of Tc-EDDA/HYNIC-TOC, a specific targeting agent for somatostatin receptor scintigraphy(2011-01); ; Marina Zdraveska Kocovska - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Comparison of Thyroid-Stimulating Hormone and Free Thyroxine Immunoassays performed on Immulite 2000 and Maglumi 800 Automated Analyzers(Scientific Fondation SPIROSKI, 2020-04-25); - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Comparative biodistribution studies of technetium-99 m radiolabeled amphiphilic nanoparticles using three different reducing agents during the labeling procedure(Wiley, 2013-12) ;Geskovski, Nikola; ;Simonoska Crcarevska, Maja ;Calis, SemaDimchevska, SimonaConsidering the confusing biodistribution data through the literature and few reported alerts as well as our preliminary biodistribution results, we decided to evaluate the interaction and interference of the commonly present (99m) Tc (technetium-99m)-stannic oxide colloid during the direct stannous chloride (99m) Tc-labeling procedure and to assess its influence on the biodistribution pattern of amphiphilic poly(lactic-co-glycolic acid) nanoparticles. In order to confirm our thesis, beside stannous chloride, we employed two different reducing agents that don't form colloidal particles. The use of sodium borohydride was previously reported in the literature, whereas sodium dithionite was adapted for the first time in the (99m) Tc direct labeling procedure for nanoparticles. The results in our paper clearly differentiate among samples with and without colloidal impurities originating from the labeling procedure with a logical follow up of the radiochemical, physicochemical evaluation, and biodistribution studies clarifying previously reported data on stannic oxide colloidal interference. (99m) Tc-nanoparticle complex labeled with sodium dithionite as reducing agent illustrated appropriate labeling efficacy, stability, and potential for further use in biodistribution studies thus providing solution for the problem of low-complex stability when sodium borohydride is used and colloidal stannic oxide interference for stannous chloride procedure. - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Schoolchildren thyroid volume in North Macedonia: data from a national survey in an iodine-sufficient country(Springer Science and Business Media LLC, 2020-02-04); ; ; ;Ittermann, TNorth Macedonia is historically iodine deficient, but due to the longstanding and effective preventive measures, it has been considered iodine replete since 2003. The aim of the recent national survey was to re-evaluate iodine status and to measure thyroid volume (TVol) by ultrasound in schoolchildren as a representative of the general population. - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Effective doses to family members of patients treated with radioiodine-131(IOP Publishing, 2011-09-23) ;Zdraveska Kocovska, M ;Vaskova, O; ; - Some of the metrics are blocked by yourconsent settings
Item type:Publication, THYROID FUNCTION TESTS DURING PREGNANCY: THE IMPORTANCE OF REFERENCE RANGE ESTABLISHMENT(Balkan Clinical Laboratory Federation, 2018-10); ; ; ;
